Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study to Compare Artesunate + Amiodaquine Versus Artemether + Lumefantrine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Occurring During 2 Years in a Cohort in Senegal

NCT00540410 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00540410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00540410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study to Compare Artesunate + Amiodaquine Versus Artemether + Lumefantrine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Occurring During 2 Years in a Cohort in Senegal
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2007
Completion date
February 28, 2009
Enrollment
366 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria